Harris makes $155M dive into health IT with Carefx purchase

Harris, a communications and IT company, has entered into a definitive agreement to acquire privately held Carefx, a developer of interoperability workflow technologies built on its Fusionfx platform, for approximately $155 million.

Melbourne, Fla.-based Harris said the acquisition will expand its capabilities in government healthcare, as well as provide an entry into the commercial healthcare market.

Founded in 2002, Carefx is headquartered in Scottsdale, Ariz., and has nearly 250 employees worldwide. The company’s Fusionfx platform is an interoperable technology suite for the retrieval, access and use of patient information. Fusionfx aggregates patient information across existing systems and delivers it in a single view to physicians at the point of care, according to Harris.

The Fusionfx platform is used in more than 800 hospitals, healthcare systems and health information exchanges across North America, Europe and Asia. Carefx also is partnered with infrastructure and health IT vendors, including Cerner, GE Healthcare, IBM and Oracle.

Under the terms of the agreement, Harris will purchase Carefx for $155 million in cash, subject to post-closing adjustments. The acquisition of Carefx is subject to customary closing conditions and is expected to close in the fourth quarter of fiscal year 2011. Harris will finance the acquisition using a combination of cash on hand and commercial paper.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup